doi: 10.3389/fnagi.2025.1495769 Received 13 September 2024 Accepted 28 March 2025 Published 09 May 2025 Volume 17 - 2025 Edited by Ramesh Kandimalla, Indian Institute of Chemical Technology (CSIR), India Reviewed by Chunchen Xiang, Capital Medical University, China Bruno piljak, University of Zagreb, Croatia Updates Copyright 2025 Li, Zhang, Yu, Xue and Hu
Frequency: Once per day
Leucine-rich repeat kinase 2 (LRRK2) inhibitor: The LRRK2 gene, identified in 2004, codes for a large protein containing serine and threonine kinase activity
Vitamin B12 injections have gained widespread popularity for their numerous health benefits, particularly for individuals who are deficient in this essential nutrient
Genetic modification is commonly used as one of the preventive strategies to reduce the pathogenicity of oncolytic viruses and improve their specificity for tumor cells